Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Hongxi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2814-4511; OpenAlex author ID A5017755999. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

  1. LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451. First author DOI 10.3892/ijo.2018.4289↗
  2. Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells. Co-author DOI 10.1111/cas.13315↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yebin Lu · 2 shared papers, 2017–2018 · strength 0.18
  2. Zhipeng Zhang · 1 shared paper, 2018 · strength 0.11
  3. Weijia Sun · 1 shared paper, 2018 · strength 0.11
  4. Weijia Sun · 1 shared paper, 2017 · strength 0.08
  5. Kun Song · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.